| 000 | 01556 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515061920.0 | ||
| 264 | 0 | _c20070911 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1111/j.1365-2133.2007.07764.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAntoniou, C | |
| 245 | 0 | 0 |
_aThe Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cApr 2007 |
||
| 300 |
_a12-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aCD11a Antigen _ximmunology |
| 650 | 0 | 4 | _aDermatology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 | _aHospital Departments |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aSkin _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStefanaki, I | |
| 700 | 1 | _aStratigos, A | |
| 700 | 1 | _aAvgerinou, G | |
| 700 | 1 | _aStavropoulos, P | |
| 700 | 1 | _aPotouridou, I | |
| 700 | 1 | _aPolidorou, D | |
| 700 | 1 | _aMoustou, A E | |
| 700 | 1 | _aKosmadaki, M | |
| 700 | 1 | _aKatsambas, A D | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 156 Suppl 2 _gp. 12-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2007.07764.x _zAvailable from publisher's website |
| 999 |
_c16926334 _d16926334 |
||